A shipment of Hydrochlorothiazide Tablets USP 12.5 mg distributed by Accord Healthcare Inc.is being voluntarily recalled after a 100 count bottle actually contained 100 Spironolactone Tablets USP 25 mg.
A pharmaceutical company has issued a voluntary nationwide recall of a popular blood pressure medication, hydrochlorothiazide, after a lot of the company's product was found to be mislabeled, the Food and Drug Administration said this week.
Since the individual lot, PW05264, of the product is involved in a potential mix-up of labeling, Accord is recalling the individual lot from the market.
Tablets of hydrochlorathiazide are circular, light peach in color and have a "1" etched on one side and an "H" on the other.
For people in possession of Accord hydrochlorothiazide tablets that do not match this description, the FDA recommends checking with a pharmacy or health-care provider.
Hydrochlorothiazide is used to treat high blood pressure "as the sole therapeutic agent or to enhance the effectiveness of other anti-hypertensive drugs in the more severe forms of hypertension", the recall notice reads.
Yankees Acquire Andrew McCutchen From Giants
Prior to his arrival in the Bay Area last winter, McCutchen spent the first nine seasons of his career in Pittsburgh. McCutchen must be on the Yankees' roster by September 1 in order to be eligible for the postseason roster.
Accord says it has received no reports of injuries because of the problem.
The drug manufacturer was tipped off to the mix-up after getting a complaint from a pharmacy that discovered the error, the company said.
NDMA is a chemical byproduct known to increase the risk of cancer in animals, and suspected of doing the same in humans.
Not all drugs containing valsartan are being recalled, but this week the FDA expanded the list of drugs being recalled.